Entecavir-Associated Thrombocytopenia: A Case Report and Review of the Pathophysiology, Diagnosis, and Treatment of a Rare but Reversible Cause of Thrombocytopenia
Table 1
Clinical criteria and levels of evidence for evaluation of patients with suspected drug-induced thrombocytopenia.
Clinical criteria
(1) Drug administration preceded thrombocytopenia; complete and sustained recovery from thrombocytopenia is noted after drug discontinuation
(2) Other drugs administered prior to thrombocytopenia were continued or reintroduced after discontinuation of the suspected drug
(3) Other etiologies of thrombocytopenia excluded
(4) Reexposure to the drug resulted in recurrent thrombocytopenia
